Home/Hedge Fund Intelligence/SELLAS Life Sciences Group, Inc.
Nasdaq: SLSStockForm 13F30 Jun 2026

Hedge funds that hold SELLAS Life Sciences Group, Inc. Equity Nasdaq: SLS

Equity · CUSIP 81642T209 · who reports it, how much, and how much it matters to them

8 of the 720 hedge fund managers we track reported shares of SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) on Form 13F for 30 June 2026. Between them they reported USD 73m. The largest position belongs to Anson Funds Management, at USD 66m.

Managers reporting it8of 720 we track
Value they reportUSD 73mshares only, 30 Jun 2026
Funds they run117with a file on PPLI.com
Largest positionUSD 66mAnson Funds Management
Typical weight0.0%median share of a manager's book
Heaviest weight3.9%Anson Funds Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

8 managers, USD 73m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports SELLAS Life Sciences Group, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Anson Funds Management8 funds on PPLI.comUSD 66m3.9%
2Renaissance Technologies13 funds on PPLI.comUSD 4.6m0.0%
3Mangrove Partners Im1 fund on PPLI.comUSD 504,0000.0%
4Sculptor Capital67 funds on PPLI.comUSD 447,0000.0%
5Walleye Capital8 funds on PPLI.comUSD 445,0000.0%
6Capital Fund Management S.A.12 funds on PPLI.comUSD 277,0000.0%
7Engineers Gate Manager1 fund on PPLI.comUSD 221,0000.0%
8Squarepoint Ops7 funds on PPLI.comUSD 155,0000.0%
Next: where it matters most
Where it matters most

For Anson Funds Management it is 3.9% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Anson Funds ManagementUSD 66m3.9%
2Mangrove Partners ImUSD 504,0000.0%
3Renaissance TechnologiesUSD 4.6m0.0%
4Sculptor CapitalUSD 447,0000.0%
5Engineers Gate ManagerUSD 221,0000.0%
6Walleye CapitalUSD 445,0000.0%
7Capital Fund Management S.A.USD 277,0000.0%
8Squarepoint OpsUSD 155,0000.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds SELLAS Life Sciences Group, Inc.

What is the ticker symbol of SELLAS Life Sciences Group, Inc.?

SELLAS Life Sciences Group, Inc. trades under the symbol SLS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 81642T209.

Which hedge funds own SELLAS Life Sciences Group, Inc. (Nasdaq: SLS)?

8 of the 720 hedge fund managers PPLI.com tracks reported SELLAS Life Sciences Group, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Anson Funds Management (USD 66m), Renaissance Technologies (USD 4.6m), Mangrove Partners Im (USD 504,000), Sculptor Capital (USD 447,000) and Walleye Capital (USD 445,000).

How many hedge funds hold SELLAS Life Sciences Group, Inc.?

8 managers in our coverage reported it, and between them they run 117 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on SELLAS Life Sciences Group, Inc.?

Anson Funds Management, where the position was 3.9% of the reported 13F book at 30 June 2026.

Does this show who is short SELLAS Life Sciences Group, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with SELLAS Life Sciences Group, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.